Saturday 17 October 2026
Export ZOMDF’s income statement to Excel — free account
Zomedica Corp.
ZOMDF Healthcare Medical Devices
Zomedica Corp.’s revenue for fiscal 2025 (year ended December 2025) was $32.0 million, up 17.4% from fiscal 2024. In the quarter to June 2026, revenue grew 36.6%, EPS grew 49.3% and free cash flow grew 40.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
0.08
0.00
0.00%
Follow ZOMDF
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 4 | 4 |
+8 more TTM periods Free account |
| (16.29%) | (18.56%) | (52.63%) | (52.41%) | ||
| (14.88%) | (17.07%) | (48.96%) | (49.00%) | ||
ROIC |
(20.54%) | (24.34%) | (84.84%) | (82.02%) | |
Return on Tangible Assets |
(27.49%) | (31.40%) | (108.41%) | (108.86%) | |
Average Days of Receivables |
59.63 | 51.05 | 39.37 | 44.98 | |
Free Cash Flow per Share |
(0.02) | (0.02) | (0.02) | (0.02) | |
Free Cash Flow |
(15.03) | (17.32) | (18.59) | (24.11) | |
Capital Expenditures |
(1.66) | (1.06) | (0.95) | (2.84) | |
| Other line items | |||||
Cash ROIC |
(9.92%) | (10.93%) | (11.03%) | (13.95%) | |
Accounts Receivable Turnover |
8.25 | 9.91 | 9.82 | 9.79 | |
Accounts Payable Turnover |
7.00 | 5.15 | 5.68 | 4.67 | |
Inventory Turnover |
2.17 | 2.06 | 1.95 | 1.72 | |
Average Days of Payables |
44.96 | 69.39 | 60.58 | 63.90 | |
Days of Inventory on Hand |
173.25 | 185.29 | 195.53 | 214.49 | |
Tax Rate |
(0.01) | (0.01) | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
15.32% | 18.84% | 22.37% | 26.04% | |
Selling, General and Administrative Expense of Revenue |
106.39% | 119.42% | 134.35% | 149.06% | |
Share Based Compensation of Revenue |
6.25% | 7.27% | 7.72% | 7.10% | |
Operating CF/Net income |
0.71 | 0.72 | 0.22 | 0.25 | |
Depreciation/Fixed assets |
0.36 | 0.35 | 0.35 | 0.33 | |
Capex/Depreciation |
(0.23) | (0.15) | (0.13) | (0.40) | |
Revenue per Share |
0.04 | 0.04 | 0.03 | 0.03 | |
Operating CF per Share |
(0.01) | (0.02) | (0.02) | (0.02) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.03 | 0.03 | 0.10 |
Columns are period end dates